Hurry - Only 2 left in stock!
CONTENTS. . Part I: The concept of evidence-based. dermatology. Andrew Herxheimer, Editor. 1. The field and its boundaries. 2. The rationale for evidence-based dermatology. 3. The role of the consumer and the public in. evidence-based dermatology. 4. The Cochrane Skin Group. Part II: The critical appraisal toolbox. Michael Bigby, Editor. 5. Formulating well-built clinical questions. 6. Finding the best evidence. 7. The hierarchy of evidence. 8. Appraising systematic reviews and meta-analyses. 9. How to critically appraise a randomized controlled trial. 10. How to assess the evidence concerning the safety of medical interventions. 11. What makes a good case series?. 12. What makes a good prevalence survey?. 13. Critical appraisal of pharmacoeconomic studies. 14. Applying the evidence back to the patient. Part III: The evidence. Part IIIa: Common inflammatory skin diseases. Luigi Naldi, Editor. 15. Acne vulgaris. 16. Papulopustular rosacea. 17. Perioral dermatitis. 18. Hand eczema. 19. Atopic eczema. 20. Seborrheic dermatitis. 21. Psoriasis. 22. Lichen planus. 23. Acute urticaria. 24. Chronic urticaria. Part IIIb: Skin cancer, moles, and photoaging. Hywel Williams, Editor. 25. Primary prevention of skin cancer. 26. Do sunscreens reduce the incidence of skin cancers?. 27. Cutaneous melanoma. 28. Squamous cell carcinoma. 29. Basal cell carcinoma. 30. Primary cutaneous T-cell lymphoma. 31. Actinic keratoses and Bowen's disease. 32. Kaposi's sarcoma. 33. Photoaging. 34. Melanocytic nevi. Part IIIc: Infective skin diseases and. exanthema. Hywel Williams and Thomas Diepgen, Editors. 35. Local treatment for cutaneous warts. 36. Impetigo. 37. Athlete's foot. 38. Onychomycosis. 39. Tinea capitis. 40. Deep fungal infections. 41. Streptococcal cellulitis/erysipelas of the lower leg. 42. Exanthematic reactions. 43. Herpes simplex. 44. Leprosy. 45. Cutaneous leishmaniasis. Part IIId: Infestations. Berthold Rzany, Editor. 46. Scabies. 47. Head lice. 48. Insect bites and stings. Part IIIe: Disorders of pigmentation. Berthold Rzany, Editor. 49. Vitiligo. 50. Melasma. Part IIIf: Hair problems. Berthold Rzany, Editor. 51. Male and female androgenetic alopecia. 52. Alopecia areata. 53. Evidence-based treatment of hirsutism. Part IIIg: Leg ulceration. Berthold Rzany, Editor. 54. Venous ulcers. Part IIIh: Other important skin disorders. 55. Cutaneous lupus erythematosus. 56. Dermatomyositis. 57. Acquired subepidermal bullous diseases. 58. Pemphigus. 59. Cutaneous sarcoidosis. 60. Erythema multiforme. 61. Stevens-Johnson syndrome and toxic epidermal necrolysis. 62. Focal hyperhidrosis. 63. Polymorphic light eruption (PLE). 64. Infantile hemangiomas and port-wine stains. 65. Psychocutaneous disease. 66. Pruritus. 67. Other skin diseases for which trials exist. Part IV: The future of evidence-based. dermatology. Luigi Naldi, Editor. 68. Where do we go from here?. Hywel Williams. Additional chapters and resources are published on the book's web site. (www.evidbasedderm.com)
Hywel Williams Professor of Dermato-Epidemiology, Nottingham UK. Professor Williams is coordinating editor of the Cochrane Skin Group. He is also the dermatology adviser for Clinical Evidence (BMJ Publishing Group) which is distributed to 500 000 doctors in the US, available free to NHS institutions in the UK and is translated into 10 languages. Michael Bigby Assistant Professor of Dermatology, Harvard University Medical School and Chief of Dermatology, Harvard University Health Service. His chief teaching interest is in evidence-based dermatology. He edited a special issue of the Archives in Dermatology devoted to ebd, which has resulted in a quarterly ebd section to which he is a continuing contributor, and he has presented papers and chaired sessions on ebd at the AAD. He has played a major part in introducing the concept in the USA. Thomas Diepgen Professor of Dematology, University of Heidelberg, Gemany is a member of European Dermato-epidemiology network and a specialist in contact dermatitis, and occupationally and environmentally acquired conditions Andrew Herxheimer Cochrane UK Center is a founding member of the Cochrane Collaboration and now a editor of the Consumer and Communications Group. He is part of the Consumer Network and the Adverse Effects Methods subgroup and also works with the Cochrane skin group. Luigi Naldi Consultant Dermatologist at Ospedale Riunit Bergamo, Italy and a member of European Dermato-epidemiology network. He specialises in psoriasis. Berthold Rzany C3-Professor for Evidence Based Medicine in Dermatology, Head of the division of Evidence Based Medicine at the department of dermatology at the Humboldt-University in Berlin. His research topics include aesthetic medicine, e.g. botulinum toxin A, collagen, hyaluronic acid, polyactic acid & other injectables, middle depth peelings as well as hyperhidrosis.
"This reference text contains valuable and current information that could be read with benefit by dermatologists and other physicians interested in cutaneous medicine. It does belong in a well-stocked personal or reference library." ( JAMA , March 2009) "This is a terrific book! All dermatologists should consider it required reading. The best designed studies, if they exist, are discussed in detail. This is a wonderful resource and should be used by anyone who considers himself/herself a relevant, educated, up-to-date dermatologist. I applaud the authors for their excellent efforts. If you aren't inclined to try to master the skills to evaluate all the studies, then just read this book. The authors have already done all the work for you." ( Doodys Book Reviews , December 2008)